PCI, Stents, Clopidogrel and Non‐cardiac Surgery

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Mar 2009 English Publisher:WileyJournal:Clinical Cardiology, volume 32, pages 113-114 (issn: 0160-9289, eissn: 1932-8737,

Copyright policy )

Authors: C Richard, Conti;

doi: 10.1002/clc.20589

pmid: 19301296

pmc: PMC6653437

PCI, Stents, Clopidogrel and Non‐cardiac Surgery

- Summary
- Subjects
- Metrics

Abstract

AbstractWhat follows in this discussion is partially abstracted from a wonderful ACCEL interview with Peter Berger by Freek W.A. Verheugt on the subject of stopping antiplatelet therapy prior to non‐cardiac surgery. 1 I suspect what Dr. Berger believes is representative of the opinion of many interventional cardiologists. Copyright © 2009 Wiley Periodicals, Inc.

Keywords

Ticlopidine, Aspirin, Cardiovascular Diseases, Surgical Procedures, Operative, Humans, Stents, Angioplasty, Balloon, Coronary, Platelet Aggregation Inhibitors, Clopidogrel

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average